[Infertility, the most adverse outcome among sexual function outcome affecting of Iranian women with polycystic ovarian syndrome]

The physical and apparent changes caused by PCOS such as hirsutism, obesity, acnea, hair loss and outcomes like infertility can cause decreased sexual function in the women affected. In the present study we aimed to evaluate the impact of PCOS clinical signs on the sexual function of married Iranian women. This cross-sectional study was carried out on 600 reproductive aged married women with PCOS selected using simple sampling from among women referring to gynecologists at private clinics. Clinical examinations and antropomethric measurements were done and a questionnaire including demographic, reproductive history, diseases and Persian version of Female Sexual Function Index were completed for all participants. Analysis was done using SPSS version 15. Approximately two third of participants had sexual dysfunction. Infertility is was found to be the most influential clinical sign of PCOS on sexual function of affected women. Subgroup analysis demonstrated that PCOS women with infertility had significantly more sexual dysfunction compared to fertile PCOS women [71 vs 61%]. Seventy-two percent of infertile women had sexual dysfunction in lubrication and arousal, while these values for fertile women were 54 and 52% respectively. Among Iranian women with PCOS, infertility affects their sexual function more than any other clinical sign, and these women experience orgasm and sexual satisfaction less than their fertile counterparts. It seems that infertility should be carefully considered during sexual consultation visits for PCOS women

[ prevalence of various phenotypes of polycystic ovary syndrome: a community-based study in southwest of Iran]

There is very little information about the prevalence of polycystic ovary syndrome at the community level; heterogeneity in diagnostic criteria and lack of universal agreement on the definition of each criterion for population based studies complicate comparability of existing literature. This study aimed to assess the prevalence of different phenotypes of polycystic ovary syndrome in a large community-based study conducted in the southwest of Iran. A total of 646 reproductive-aged women were randomly selected using the stratified, multistage probability cluster sampling method. The prevalence of polycystic ovary syndrome according to the Rotterdam criteria and its various phenotypes were estimated using universal assessment of ultrasonographic parameters, hormonal profiles and clinical histories. The estimated prevalence of polycystic ovary syndrome in this population based study using the Rotterdam criteria was 14.1[n=85]. There were 279 [46.3%] women who had no symptoms of polycystic ovary syndrome and were completely normal. Among women with polycystic ovary syndrome, phenotypes A, B, C and D were observed in 11, 19, 42 and 13 women, respectively. The most common symptoms observed in this study in order of frequency were hyperandrogenism, polycystic ovary on sonography and menstrual disorders, indicating the need for more studies on the priority of paraclinical assessment, based on universal agreement on definitions for the diagnosis of polycystic ovary syndrome